Effects of gelonin immunoconjugate of monoclonal antibody MSN-1 to endometrial adenocarcinoma on antigen-producing tumor cells in vitro

Oncology Reports

Volumn 4, Issue 2, 1997, Pages 331-336

  Kaneta, Yoshibumi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

endometrial adenocarcinoma; gelonin; missile therapy

Indexed keywords

GELONIN; GELONIN ANTIBODY CONJUGATE; IMMUNOTOXIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; DRUG TARGETING; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0031027232     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.4.2.331     Document Type: Article

References (3)

1. Fulton RJ, Uhr JW and Vitetta ES: The effect of antibody valency and lysosomotropic amines on the synergy between ricin A chain - and riein B chain-containing immunotoxins. J Immunol 136: 3103-3109, 1986.
2. Vitetta ES, Fulton RJ, May RD, Till M and Uhr JW: Redesigning nature's poisons to create anti-tumor reagents. Science 238: 1098-1104, 1987.
3. Wiels J, Junqua S, Dujardin P, Le Pecq JB and Tursz T: Properties of immunotoxins against a glycolipid antigen associated with Burkitt's lymphoma. Cancer Res 44: 129-133, 1984.